embecta completes spin-off from BD and lists on NASDAQ as a global leader in diabetes care 100-year legacy in insulin delivery Largest producer of diabetes injection devices in the world Over 2,000 employees globally serving more than 100 countries. FRANKLIN LAKES, N.J., April 01, 2022...